Title:
PYRROLOPYRAZOLE SPIRO COMPOUND
Document Type and Number:
WIPO Patent Application WO/2023/072191
Kind Code:
A1
Abstract:
Disclosed are a pyrrolopyrazole spiro compound, and the use thereof in preparing a drug for treating related diseases. The present invention specifically relates to a compound as represented by formula (I'), and a stereoisomer and a pharmaceutically acceptable salt thereof.
Inventors:
FU XIANGYU (CN)
DING CHARLES Z (CN)
HU LIHONG (CN)
DING CHARLES Z (CN)
HU LIHONG (CN)
Application Number:
PCT/CN2022/127937
Publication Date:
May 04, 2023
Filing Date:
October 27, 2022
Export Citation:
Assignee:
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN)
MEDSHINE DISCOVERY INC (CN)
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D471/20; A61K31/438; A61P35/00
Domestic Patent References:
| WO2022207924A1 | 2022-10-06 | |||
| WO2020073949A1 | 2020-04-16 |
Foreign References:
| CN110143949A | 2019-08-20 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: